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RNA degradation: Sm-like proteins wRING the neck of mRNA
Barbara K. Pannone and Sandra L. Wolin
Ring-shaped structures containing seven Sm or Sm-like
proteins are stable components of several small
nuclear ribonucleoprotein particles that function in
pre-mRNA splicing. Recent reports describe a role for a
distinct complex of seven Sm-like proteins in a very
different process: mRNA degradation.
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To produce functional mRNA, a newly transcribed RNA
undergoes several processing reactions. Following
transcription, the 5¢ end of the mRNA is capped by the
addition of a methylated guanine residue, intervening
sequences in the body of the mRNA are removed by
splicing, and a poly(A) tail is added to the 3¢ end of the
mRNA. The major players in the process of pre-mRNA
splicing are several small ribonucleoprotein particles,
known as U snRNPs. Seven small proteins, the Sm
proteins — named because they react with anti-Sm
autoantibodies from patients with rheumatic disease —
form a heptameric ring that functions in the biogenesis of
the U snRNPs. A similar ring complex, containing seven
‘Sm-like’ proteins, binds and stabilizes the spliceosomal
U6 snRNA. Recent studies have now shown that a
related complex of seven Sm-like proteins functions at
the other end of the mRNA life cycle, in mRNA degrada-
tion. These new results suggest that heptameric ring
complexes play a broad role in RNA metabolism.
The best-studied members of the Sm and Sm-like
protein family are the seven Sm proteins — SmB, SmD1,
SmD2, SmD3, SmE, SmF and SmG — that stably associ-
ate with the spliceosomal U1, U2, U4 and U5 snRNAs.
Binding of these seven proteins to the snRNAs, which
occurs in the cytoplasm of vertebrate cells, is important
for hypermethylation of the 5¢ cap of the snRNAs, for
import of the assembled snRNP into the nucleus, and for
binding of snRNP-specific proteins (reviewed in [1]).
While the Sm proteins remain associated with the
snRNAs in their final site of function — the spliceosome
— it is not known whether these proteins participate in
the splicing reaction. All Sm proteins share a conserved
domain, known as the Sm motif. From the crystal struc-
tures of two Sm protein heterodimers [2], together with
other biochemical and genetic data, a model was pro-
posed in which the Sm proteins interact with one another
through their Sm motifs to form a seven-membered ring.
The central hole of this ring, which is sufficient to
accommodate single-stranded, but not double-stranded
RNA, is predicted to bind a conserved U-rich sequence
found in all RNAs bound by the Sm proteins [2].
In addition to the Sm proteins, other proteins contain the
conserved Sm motif, although they are not associated with
U1, U2, U4 or U5 snRNAs. There are nine of these Sm-
like proteins in yeast — named Lsm1–Lsm9 for ‘Like Sm’
— and homologs of Lsm1 to Lsm8 have been identified in
humans [3–5]. Sm-motif-containing proteins have even
been identified in archeabacteria, suggesting that
members of the Sm and Sm-like family originated from a
common ancestor [3–5]. Seven Sm-like proteins,
Lsm2–Lsm8, associate with another spliceosomal snRNA,
U6 [3,4,6]. U6 RNA differs from the other spliceosomal
U snRNAs in that it is synthesized by RNA polymerase
III, while the other U RNAs are made by RNA poly-
merase II (the same polymerase which synthesizes
mRNA). In addition, U6 RNA lacks a canonical Sm
protein binding site and is not bound by the Sm proteins. 
While the U1, U2, U4 and U5 snRNAs transit to the
cytoplasm during their biogenesis, the U6 snRNP assem-
bles entirely within the nucleus. The Lsm2–Lsm8 proteins
are required for the stability of U6 RNA and for its assem-
bly into a functional snRNP [3,4,6]. In a similar manner to
the Sm proteins, the Lsm proteins remain associated with
U6 RNA within the spliceosome, although their function
in splicing is not known. By electron microscopy, the puri-
fied human Lsm2–Lsm8 complex resembles a doughnut,
similar in size and shape to the core Sm snRNPs [5]. As
each Lsm protein can be specifically aligned with one of
the seven Sm proteins [3–5], the Lsm2–Lsm8 proteins
most likely assemble into an analogous seven-membered
ring. But while the Sm proteins form a stable heptameric
complex only in the presence of RNA, the Lsm2–Lsm8
complex can be isolated as an RNA-free ring [5].
Although these data support the view that the Sm and
Lsm ring complexes have roles in spliceosomal snRNP
biogenesis and stability, at least one Sm-like protein,
Lsm1, does not fall into this theme. Firstly, no U
snRNAs are known to associate with this protein [3,4].
And secondly, Boeck et al. [7] showed that Lsm1 is
involved in mRNA decapping. A common mechanism of
mRNA degradation in yeast involves trimming of the
poly(A) tail, followed by removal of the 5¢ cap by the
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decapping enzyme Dcp1. After decapping, the mRNA is
rapidly degraded by the 5¢-to-3¢ exoribonuclease Xrn1
(reviewed in [8]). Mutations in several other genes,
including MRT1 and MRT3, affect the efficiency of
decapping. Yeast cells carrying a mutation in LSM1 accu-
mulate capped, deadenylated mRNAs, suggesting that
Lsm1 is yet another factor that influences the rate of
mRNA decapping [7].
In two recent papers [9,10], this story has come full
circle. These papers demonstrate that the Lsm1–Lsm7
proteins form a distinct complex that participates in
mRNA decay [9,10]. In addition to the Lsm2–Lsm8
complex that binds U6 RNA, a second complex, consist-
ing of Lsm1–Lsm7, can be purified from yeast [9]. Asso-
ciated with the Lsm1–Lsm7 complex is Xrn1, the major
5¢-3¢ exonuclease involved in mRNA decay, as well as
Pat1, a protein identified as a topoisomerase-II-associ-
ated protein but now shown to be identical to Mrt1, one
of the gene products previously implicated in mRNA
decapping [9,10]. Furthermore, Dcp1, the mRNA decap-
ping enzyme, co-immunoprecipitates with the
Lsm1–Lsm7 proteins, as does a small amount of mRNA
[10]. As the interaction of Lsm1–Lsm7 with Dcp1 (but
not Pat1) is RNase-sensitive, Dcp1 may interact with the
Lsm1–Lsm7 complex through the mRNA. Like Lsm1,
the Lsm2–Lsm7 proteins play a role in mRNA decap-
ping, as cells carrying either mutations or deletions of
these genes accumulate capped, deadenylated mRNAs
[9,10]. Thus, not only do heptameric rings of Sm and Sm-
like proteins participate in mRNA biogenesis — through
stable binding to the spliceosomal U snRNAs — but they
also participate in mRNA degradation (Figure 1).
How can the substitution of one component of the ring
complex — Lsm1 for Lsm8 — specify an entirely
different function? Part of the answer may be a matter of
cellular localization. Lsm1 localizes primarily to the cell
cytoplasm [10,11], whereas Lsm7, a component of both
the Lsm1–Lsm7 and the Lsm2–Lsm8 rings, localizes to
both the nucleus and cytoplasm [10]. Thus, the
Lsm1–Lsm7 complex is mainly cytoplasmic, consistent
with a function in mRNA degradation, whereas the
Lsm2–Lsm8 complex is probably nuclear, consistent
with a function in U6 snRNA assembly and stability. 
Substitution of Lsm1 for Lsm8 could also alter the RNA
binding specificity of the complex. The Lsm2–Lsm8
complex binds to the uridylate-rich 3¢ end of U6 snRNA
[5,12]; the binding site for Lsm1–Lsm7 on mRNA has not
yet been reported. In this regard, it is interesting that
Lsm1 and Lsm8 are both highly related to the SmB
protein. In humans, SmB (but not other Sm proteins) exists
in three closely related forms. SmB pre-mRNA can be
alternatively spliced to yield either SmB or SmB¢, which
differ only at the carboxyl terminus. SmB and SmB¢ are
expressed at high levels in almost all human tissues except
the brain, where SmN, a neural-specific SmB protein,
replaces SmB¢ [13]. The function of these SmB variants is
unknown, but they could provide a way of subtly altering
the function/and or binding specificity of the Sm ring.
Why do RNAs bind ring structures and how might these
complexes function? Ring structures are not new to the
cell. Both chaperonins (protein folding machines) and
proteasomes (protein degradation machines) assemble
into multi-layered ring complexes (reviewed in [14]).
These rings allow compartmentalization of the substrate
proteins from the rest of the cellular environment. But
while the chaperonin and proteasome cavities are large
enough to accommodate entire proteins, electron
microscopy of the Lsm2–Lsm8 complex suggests that it
is only 3–5 nm thick [5]. Thus, the Sm and Lsm rings
may protect only 5–16 nucleotides, depending on
Figure 1
Three different heptameric complexes contain Sm or Sm-like proteins.
The Sm proteins bind a single-stranded uridine-rich sequence that is
often found between two helices in the spliceosomal U snRNAs. The
Lsm2–Lsm8 proteins bind the uridine-rich tract at the 3¢ end of U6
snRNA. The binding site of the Lsm1–Lsm7 complex on mRNA has
not been determined. The order of the proteins around the Sm and
Lsm rings is based on the model of Kambach et al. [2] and has not yet
been verified experimentally.
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whether the bases are stretched out or stacked, suggest-
ing that these rings play a somewhat different role. 
One possibility is that the Sm and Lsm rings, by forcing
the RNA inside to be single-stranded, promote either
protein–RNA or RNA–RNA rearrangements [10]. In this
scenario, the Sm and Lsm2–Lsm8 rings may facilitate
snRNA rearrangements that occur during snRNP biogene-
sis and/or pre-mRNA splicing. Binding of the Lsm1–Lsm7
ring to deadenylated mRNA could disrupt RNA structure
and/or displace bound proteins, thus facilitating decapping
and RNA degradation. This model would imply that, in
addition to their known high-affinity binding sites on
U snRNAs, the Sm and Lsm2–Lsm8 rings may be capable
of sliding to some degree along these RNAs. An alterna-
tive, but not exclusive, possibility is that the rings serve as
scaffolds for binding of helicases and/or other enzymes,
such as the cap modification enzymes (in the case of the
Sm ring) or exonucleases (for the Lsm1–Lsm7 ring).
Consistent with this idea, a putative RNA helicase,
Gemin3, was demonstrated to co-immunoprecipitate with
the Sm proteins and interact directly with SmB [15].
Interestingly, Lsm1 was recently shown to be a host factor
for replication of brome mosaic virus (BMV), a member of
the alphavirus family of positive-stranded RNA viruses
[11]. This virus can replicate in the cytoplasm of the yeast
Saccharomyces cerevisiae, allowing genetic identification of
host factors that assist replication. In the presence of a
mutation in Lsm1, stabilization of one of the BMV
genomic RNAs by a virus-encoded replication protein fails
to occur. Although it seems contradictory that Lsm1 could
facilitate both cellular mRNA degradation and viral RNA
stabilization, the mechanism by which Lsm1 functions
could be similar in both processes. For example, the viral
replication protein could compete with the mRNA
degradation machinery for association with Lsm1. As
binding of the Lsm1–Lsm7 complex to deadenylated
mRNA facilitates the interaction of mRNA decapping and
degradation enzymes with mRNA, binding of the same
complex to the BMV genomic RNA — which lacks a
poly(A) tail — could facilitate interaction of the replication
proteins with the RNA, by promoting RNA rearrange-
ments or by binding factors that allow interaction of the
replication protein with the BMV genomic RNA. Interest-
ingly, the replication protein contains both RNA capping
and helicase domains [16]. Thus, for both cellular mRNAs
and the viral genomic RNA, Lsm1 may facilitate inter-
actions of enzymes that modify the 5¢ end of RNAs with
their RNA substrates. As binding of the Sm protein ring to
U snRNAs allows hypermethylation of the caps of these
RNAs [1], a general role of these rings could be to
promote modification of the 5¢ ends of their bound RNAs. 
Lastly, if substitution of a single component of the Sm or
Sm-like protein ring can define a new function, could there
be even more complexes of these proteins in the cell? In
yeast, Lsm2–Lsm7, but not Lsm1, Lsm8 or Lsm9, associate
with a second RNA polymerase III transcript, the precursor
to the RNase P RNA [4], suggesting the existence of yet
another ring. Although the yeast Lsm9 protein has not been
described to interact with other Lsm proteins, it could also
form part of another complex. Moreover, given the high
degree of homology between Sm and Lsm proteins, rings
containing mixtures of Sm and Sm-like proteins may exist.
In this regard, we note that at least two RNAs bound by the
Sm proteins, the U7 RNA — which functions in histone 3¢
end processing — and an RNA of unknown function known
as X8, contain non-canonical binding sites for the Sm pro-
teins [17,18]. In the case of U7 RNA, conversion of this
unusual binding site to the consensus site yields a non-func-
tional snRNP [17]. One explanation could be that the Sm
heptameric rings that bind these RNAs differ slightly in
composition from the ring that binds the U1, U2, U4 and U5
RNAs. In all likelihood, future studies on the Sm and Sm-
like family of proteins and their associated RNAs will con-
tinue to provide new and surprising insights into the roles of
these ring complexes in facilitating RNA processing events.
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